<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>avapritinib repurposing &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/avapritinib-repurposing/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 13 Mar 2025 19:13:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>avapritinib repurposing &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>FDA-Approved Drug Reimagined for Potential High-Grade Glioma Treatment</title>
		<link>https://bioengineer.org/fda-approved-drug-reimagined-for-potential-high-grade-glioma-treatment/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 13 Mar 2025 19:13:03 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[avapritinib repurposing]]></category>
		<category><![CDATA[blood-brain barrier penetration]]></category>
		<category><![CDATA[collaborative oncology research]]></category>
		<category><![CDATA[high-grade glioma therapy]]></category>
		<category><![CDATA[PDGFRA gene mutations]]></category>
		<guid isPermaLink="false">https://bioengineer.org/fda-approved-drug-reimagined-for-potential-high-grade-glioma-treatment/</guid>

					<description><![CDATA[High-grade glioma represents a particularly aggressive form of brain cancer, affecting both pediatric and adult populations. This type of tumor is notoriously difficult to treat due to specific challenges associated with its location within the brain, the high likelihood of recurrence after initial therapies, and the significant barrier posed by the blood-brain barrier, which limits [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">238377</post-id>	</item>
	</channel>
</rss>
